LOXO
Loxo Oncology, Inc
LOXO
LOXO
Delisted
LOXO was delisted on the 14th of February, 2019.
213 hedge funds and large institutions have $5.11B invested in Loxo Oncology, Inc in 2018 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 67 increasing their positions, 62 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 62
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
213
Holding in Top 10
6
Calls
$50M
Puts
$32.5M
Top Buyers
| 1 | +$102M | |
| 2 | +$55.1M | |
| 3 | +$53.4M | |
| 4 |
BlackRock
New York
|
+$48.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.6M |
Top Sellers
| 1 | -$353M | |
| 2 | -$119M | |
| 3 | -$69.9M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$46.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$36.8M |